SCHEMBL7404378

SCHEMBL7404378

COC(=O)c1ccc(N2CCN(CCC3CCc4ccccc43)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.52
HTR1A P08908 2/20 0.49
DRD2 P14416 1/20 0.49
DRD4 P21917 1/20 0.49
HTR1D P28221 1/20 0.49
HTR2A P28223 1/20 0.49
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.48
HTR2C P28335 1/20 0.47
POLB P06746 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7401818 0.99 MAPT (0.51) MAPTHTR1ADRD2DRD4HTR1D
SCHEMBL7403486 0.86 DRD2 (0.50) HTR1ADRD2DRD4HTR1DHTR2A
SCHEMBL7397854 0.84 DRD4 (0.68) HTR1ADRD2DRD4HTR1DHTR2A
Hydrochloric Acid SCHEMBL8185604 0.83 DRD4 (0.67) HTR1ADRD2DRD4HTR1DHTR2A
SCHEMBL7405539 0.82 ALDH1A1 (0.53) MAPTHTR1ADRD2DRD4HTR1D
SCHEMBL9052228 0.82 DRD2 (0.47) MAPTHTR1ADRD2DRD4HTR2A
Hydrochloric Acid SCHEMBL8185523 0.81 ALDH1A1 (0.52) MAPTHTR1ADRD2DRD4HTR1D
SCHEMBL27464824 0.80 HTR2C (0.47) HTR2CSIGMAR1
SCHEMBL7401217 0.80 PARP1 (0.51) MAPTDRD2DRD4HTR1DSIGMAR1
Hydrochloric Acid SCHEMBL7395941 0.79 PARP1 (0.50) MAPTDRD2DRD4HTR1DSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP claimed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO claimed
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed